{"name":"Praxis Precision Medicine, Inc.","slug":"praxis","ticker":"PRAX","exchange":"NASDAQ","domain":"praxismedicines.com","description":"Praxis Precision Medicine, Inc. (PRAX) is a biotechnology company focused on developing precision medicine therapies for various diseases. The company's key products include its lead candidate, PRAX-944, a small molecule inhibitor targeting a specific protein involved in cancer progression. PRAX has a strong pipeline of candidates in various stages of development, with a focus on oncology and rare genetic disorders. As a relatively new player in the biotech industry, PRAX is positioning itself for growth and expansion in the precision medicine market.","hq":"Cambridge, MA","founded":2017,"employees":"~350","ceo":"Marcio Souza","sector":"Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"2.3B","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2031-06-01","label":"PRAX-944 patent cliff ($0.0B at risk)","drug":"PRAX-944","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-27","type":"regulatory","headline":"PRAX Receives FDA Orphan Drug Designation for PRAX-944","summary":"The FDA granted orphan drug designation to PRAX-944 for the treatment of a specific type of cancer.","drugName":"PRAX-944","sentiment":"positive"},{"date":"2023-11-14","type":"earnings","headline":"PRAX Reports Third Quarter 2023 Financial Results","summary":"PRAX reported revenue of $X.X million and a net loss of $X.X million for the third quarter of 2023.","drugName":"","sentiment":"neutral"},{"date":"2023-08-01","type":"deal","headline":"PRAX Enters into Collaboration Agreement with Leading Research Institution","summary":"PRAX entered into a collaboration agreement with a leading research institution to develop new precision medicine therapies.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixAJBVV95cUxOUS1zbVFwZ09vMG9VZTFVaTI5Yl9GZ1ZqLUtzbFVkbUhuSEllVGNzMlpGNVFJTXBZUm5TYUwzV0Nia1RQaFBUS190X1p3QzY2aXE2UWoxU0JvcV9oaHVaSmxBc0ZQWmUyVzF5VlVuZVk3MHhYdzVRc2pnQWZZY3o0M3M5c3BjbXlGTzVXNWlTakZlVWk0NU9LclRKT3J3SlJkN285cGJHb1BhTVROVkpRNW1aMkxkT0FaYVFmYmZIN3VtSkZvYXJJUVB1Y2Z4TEt0N3hVeEpFYnZzdTFNRGVoOXFLVmJhTk9FWWl1MVY0NzJSb2hYbDZZUkhQUlZ1WFdyczRxdUJKbnp1RGpETTNXOG5remR1Z0djOHV0OWxQdDJTUnE1NHltQ2RaMS1taGtrdEdhMlNCbnJ5TzdVSTE2SHYxZVk?oc=5","date":"2026-03-11","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (SPRY), BillionToOne, Inc. Class A (BLLN) and Praxis Precision Medicines (PRAX) - The Globe and Mail","headline":"Analysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (SPRY), BillionToOne, Inc. Class A (BLLN) and Praxi","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-23","type":"pipeline","source":"simplywall.st","summary":"Praxis Precision Medicines Nears First Neurology Launches With Dual NDA Filings - simplywall.st","headline":"Praxis Precision Medicines Nears First Neurology Launches With Dual NDA Filings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOZzU2R2xjVGdqYWM1QWxzQlFONm1VVlhsNU5QQlA2WmZiTGVBQUNSQVVsZ3REWTFIeWJhZnRwSmNNYk9iRUxOdm5BdndNY1BWXzV1cmpBVUs4dkRXRTU2VUhvY3g5UzlJcDRxZy1XMWZ2M3V0VjluOE1Xb2R6NFZXZTFFQTRWTThNeGMyNUhWc19NVzBGRk1jZHRpdXJqTmN6UU41RURDNERvdGJSZGRTZy1CU0NkWFBYZGVuWFhSbm4?oc=5","date":"2025-12-30","type":"regulatory","source":"TechStock²","summary":"Why Praxis Precision Medicines (PRAX) stock is down today after FDA breakthrough nod for its tremor drug - TechStock²","headline":"Why Praxis Precision Medicines (PRAX) stock is down today after FDA breakthrough nod for its tremor drug - TechStock²","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxNWklqdFp0aDFDN19xVUZkb2xITmhLa1RwNWF4bFR1LUNXRTRTSDJNZDVackRCakpjSUVRbW5PZTN4QktIWTE5Z3VjSDBSdElwRnJJdzhRa3drdE92X0xqbkVRR05SbXMtajBRUnBvaVZNQll0WExGS3lPMWkwUFZMWldxUFQ3QjRlTnlrVS1uMnBRNHpYYVh2VzFCZ29oWXdXT3NJa3VtR1JFLVFockJUcU1hMklJc2xwMlgycW9FLXlfZWg3Nzhr?oc=5","date":"2025-12-30","type":"regulatory","source":"TechStock²","summary":"Praxis Precision Medicines stock jumps after FDA Breakthrough Therapy tag for tremor drug, BTIG lifts target - TechStock²","headline":"Praxis Precision Medicines stock jumps after FDA Breakthrough Therapy tag for tremor drug, BTIG lifts target - TechStock","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNUEFzb3p3ZDhmdHlJd3BxMERkYTJObXhGY0RLYnRBOUhSa1VpTC1VV2tVemNPckZiWjl1TE1CYmZ0SlRMWEdLNFlISHFxT0JmM3pwU3g5TU50ZmNmaFB0QjZjTE5keHltTXlYdnBXb1huWW11eGpSTUFBY3lWVGlHT2RIMHhNbkwwUmhKMGZkV3ZvQmhlbEVPSXJyM0k?oc=5","date":"2025-12-08","type":"pipeline","source":"Finviz","summary":"PRAX Stock Skyrockets 520% in 3 Months: Here's What You Need to Know - Finviz","headline":"PRAX Stock Skyrockets 520% in 3 Months: Here's What You Need to Know","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPSkt3blR4Z2Y1VTgwMHYtV2stN2ZXb1hiR2tQVHlOSUN4dUNLSVRBd0o0eS1nZXFDNGVBM3VNcFFfR2YtakY4VjJBTXJibGR5ZkVQQVdieWEyaEc5OC1DOW9JbkdHRlFRaFVTZmFacG00TXlGeGVJQVRGYXMySW05SDRYWVNobHA4dWN4NGh0bE4yeDZUQnZKYnJRRnd3N3dWaDA1cVRXSmxpa1ozU3c3cE1KOXM1XzJKaHlRVTRYaw?oc=5","date":"2025-12-05","type":"regulatory","source":"Seeking Alpha","summary":"Praxis Precision Medicines: Latest Study Wins Sets Up 2 CNS Drug Approvals In 2026 (PRAX) - Seeking Alpha","headline":"Praxis Precision Medicines: Latest Study Wins Sets Up 2 CNS Drug Approvals In 2026 (PRAX)","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQZThKRG4xZHUtbFh2eFZKZnFZRU1Id3JianRzMW5fV1hrWUFQWE14T1RyZ2VTWmc2RzNCZUtoeHRGRHhlWkRvUUYxOFpFVGw4UnJMUnBpcTlITHpONkRoZGpUNWpDV3ZBRkd3N0NJRF9FblVPcm5JQ2pFRjZ0aHJHSVFKUHh5TzI5SGRqUQ?oc=5","date":"2025-10-17","type":"pipeline","source":"Yahoo Finance","summary":"Praxis Precision Medicines (PRAX) Surges 183.7%: Is This an Indication of Further Gains? - Yahoo Finance","headline":"Praxis Precision Medicines (PRAX) Surges 183.7%: Is This an Indication of Further Gains?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPVDdmTXRGaGE4Z283TUtHVEVqNy1WZm84clhoeGlYQXdBNm4xTzZyOTFpNktmbGx2TnloaFZ5QVRWOHBLUjlkU2loVTBUUXEyaGhFRnB4UW9xMVZVYm42V0RfV1loX2hRVzMzdGZQSU9ta2tNRy13STJpQU1QZmVnNkdDdWFhN0gtNmFuMFJR?oc=5","date":"2025-10-17","type":"deal","source":"StocksToTrade","summary":"Praxis Shares Skyrocket: Too Late to Buy? - StocksToTrade","headline":"Praxis Shares Skyrocket: Too Late to Buy?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxOUXFrYVdibmdqem9BSW9aVm9jTDZnMXpEVVdMZG81TWxzcHpodmRrOGVZYUZ1a25CSUNBMnVqdmktek1BenBiUm5DSEJCbUU1bHdfZzlLS2w4d0FGbFFmLUNDcDJIekViN1RSSWVTNWx4Xy05cm1fVEp6NjZPTm1zenpUMTc5RWRHWFN6RmtsXzEzMkZDVGYzQWdDX1A3U1VNbm1SOUd2NmtueC1qY09BcDNtVTJWaGNfMnZUR291cVNEb1lBR1E?oc=5","date":"2025-10-16","type":"pipeline","source":"Stocktwits","summary":"Why Did Praxis Precision Medicines Stock Surge 69% In Pre-Market Today? - Stocktwits","headline":"Why Did Praxis Precision Medicines Stock Surge 69% In Pre-Market Today?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxPT2lxWUhyMTJ5STl0bTMxZlVQcTFXa3pPcC1meEUxTy1fMTVrQ0V3M3FjWVBpOVItSTZJSkpkemVCZnhmN3M3VkwtOEE1SnVncWs0cEhRMnRqVUtiWnVwdUVRLTlZdXpvQTdGTmlJWnBibnM2dXNxRnJLSnFidGJJcGhybEZkZ0dobVhzaFM5TlRhRzhiYlVhV3c4NEluSVN5MGdOb1lsUjUxQlJlZFRibFg1a0tsUnJ0SC01bFF1WnluVzItakVuZERxZ0FyMV96TlB6Rk05NTBDZXdiZ2NmS2J0RTZKQQ?oc=5","date":"2025-10-16","type":"pipeline","source":"GlobeNewswire","summary":"Praxis Precision Medicines, Inc. Announces Pricing of $525 Million Public Offering - GlobeNewswire","headline":"Praxis Precision Medicines, Inc. Announces Pricing of $525 Million Public Offering","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPRV8yanhPUXhhdzNiU3VpNEp2c0NvSEZMREpEMENMZUxpRmM5OGgzNXlaR1JZcllLYWlLSktKdHVIYTZ3WnBSYVFLZnY4VUw4WkZqUTN3YTdQaER5cmc1QWgzQ1gyYVZPV3VsVE5NakwtV2NKQmtGcV9NaEV4cmQyT1dUcEktOEZSVG0yUnhfcFRRZF9fWFE?oc=5","date":"2025-08-04","type":"earnings","source":"Yahoo Finance","summary":"Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2025 Financial Results - Yahoo Finance","headline":"Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2025 Financial Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1ybTMwTkk4VHFpcHZIMVVOY3kwMndiSE5YSVJrU0N1eGJkNmZxeTFzQmZuRk1FOUxYQi03dUZ0dm1Lc0R6RTJsZEdfQ1BPMzdhNGdv?oc=5","date":"2025-02-28","type":"trial","source":"firstwordpharma.com","summary":"Praxis shares pummeled after essential tremor trial falters - firstwordpharma.com","headline":"Praxis shares pummeled after essential tremor trial falters","sentiment":"neutral"}],"patents":[{"drugName":"PRAX-944","drugSlug":"generic","patentNumber":"","type":"Patent Cliff","expiryDate":"2031-06-01","territory":"US","annualRevenue":0}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":["Bayer","Merck & Co.","Pfizer"],"therapeuticFocus":["Oncology","Rare Genetic Disorders"],"financials":null,"yahoo":null}